期刊文献+

双歧杆菌抑制小鼠实验性结肠炎肠道炎症反应的研究 被引量:13

The research on bifidobacterium inhibits inflammatory response in murine experimental colitis
原文传递
导出
摘要 目的观察补充益生菌对葡聚糖硫酸钠(DSS)诱导的小鼠结肠炎的影响,探讨益生菌对结肠炎的治疗作用和可能机制。方法将小鼠分为4组:正常对照组、DSS组、柳氮磺胺吡啶(SASP)组和双歧杆菌组。建立小鼠急性DSS结肠炎模型。SASP组在饮DSS水同时予SASP灌胃。双歧杆菌组在实验开始前7d予双歧杆菌灌胃至实验结束。每天观察各组疾病活动指数(DAI),并在实验结束后检测各组小鼠炎症肠段肿瘤坏死因子(TNF)α、核因子(NF)κBP65、髓过氧化物酶(MPO)等的表达。结果自实验第4天开始,SASP组和双歧杆菌组DAI明显低于DSS组。实验结束时,SASP组和双歧杆菌组炎症肠段TNFα[(10.01±1.11)和(10.45±0.98)pg·mg-1·ml-1]、MPO[(3.21±0.20)和(3.24±0.16)U/g组织]等的水平较DSS组[(13.35±1.01)pg·mg-1·ml-1和(3.63±0.23)U/g组织]均明显降低,NFκBP65阳性的炎症细胞数减少。结论给小鼠预服双歧杆菌能有效抑制炎症肠段炎症细胞NFκB的活化及炎性细胞因子的分泌,减轻肠道炎症反应。 Objective To investigate the effect of bifidobacterium (Bif) supplementation on acute inflammatory response in murine dextran sulfate sodium(DSS)-induced colitis, and its possible mechanism. Methods Mice were divided into four groups: control,DSS, salfasalazine (SASP) and Bif. The mice in groups DSS, SASP and Bif were fed with 5% DSS(w/v) solution for 7 days to induce colitis, and disease activity index (DAI) was calculated every day. The mice in group SASP were fed with SASP every day during inducing colitis, and the mice in Bif group were given Bif by oral gavage from 7 days before the experiment to the end of experiment. The expression of TNF-α、NF-κB P65 and myeloperoxidase (MPO) in inflamed colon of each group was measured at the end of experiment. Results The mice in groups SASP and Bif showed a lower DAI than those in group DSS since the forth day to the end of experiment. There were lower level of TNF-α and MPO in murine inflammatory colon, and lower NF-κB P65 expression in nuclei of inflammatory cells in groups SASP and Bif than those in control at the end of experiment. Conclusions Treatment with Bif can effectively inhibit proinflammatory cytokine secretion and NF-κB activation in inflammatory cells, and decrease colonic inflammatory response in DSS induced colitis.
出处 《中华消化杂志》 CAS CSCD 北大核心 2005年第6期344-347,共4页 Chinese Journal of Digestion
关键词 双歧杆菌 实验性结肠炎 葡聚糖硫酸钠 炎症 Bifidobacterium Experimental colitis Dextran sulfate sodium Inflammation
  • 相关文献

参考文献12

  • 1Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut, 2003, 52: 237-242.
  • 2Cummings JH, Macfarlane GT, Macfarlane S. Intestinal bacteria and ulcerative colitis. Curr Issues Intest Microbiol, 2003, 4:9-20.
  • 3Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol, 1995, 102:448-455.
  • 4Kanauchi O, Mitsuyama K, Araki Y, et al. Modification of intestinal flora in the treatment of inflammatory bowel disease.Curr Pharm Des, 2003, 9: 333-346.
  • 5Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis.Lab Invest, 1993, 99: 239-249.
  • 6Murano M, Maemura K, Hirata I, et al. Therapeutic effect of intracolonically administered nuclear factor κB ( p65 ) antisense oligonucleotide on mouse dextran sulphate sodium ( DSS )induced colitis. Clin Exp lmmunol, 2000, 120: 51-58.
  • 7Fabia R, Ar'Rajab A, Johansson ML, et al. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scand J Gastroenterol, 1993, 28: 155-162.
  • 8Tannock GW. Exploring the relationships between intestinal microflora and inflammatory conditions of the human bowel and spine. Antonie Van Leeuwenhoek, 2002, 81: 529-535.
  • 9Egger B, Bajaj-Elliott M, MacDonald TT, et al. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion, 2000, 62: 240-248.
  • 10Schottelius AJ, Baldwin AS. A role of transcription factor NF-κB in intestinal inflammation. Iht J Colorectal Dis, 1999, 14:18-28.

二级参考文献19

  • 1Schreiber S,Nikolaus S,Hampe J.Activation of nuclear factor κB in inflammatory bowel diseaseGut,1998.
  • 2Baeuerle P A;Henkel T.Function and activation of NF-κB in the immune system,1994.
  • 3Schreiber S;Raedler A;Stenson WF.The role of mucosal immune system in inflammatory bowel disease,1992.
  • 4Neurath MF;Meyer KH.Protective and pathogenic roles of cytokines in inflammatory bowel disease,1996.
  • 5Baldwin AS.The NF-κB and IκB proteins:new discoveries and insights[J],1996(0).
  • 6Verma IM;Stevenson JK;Schwarz EM.Rel/NF-κB/IκB family: intimate tales of association and dissociation,1995.
  • 7Reg AA;Baldwin AS.The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors,1993.
  • 8Miyamoto S;Verma IM.Rel/NF-κB/IκB story[J],1995.
  • 9Regnier CH;Song HY;Gao X.Identification and characterization of an IκB kinase[J],1997.
  • 10May MJ;Ghosh S.Signal transduction through NF-κB[J],1998.

共引文献4

同被引文献140

引证文献13

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部